These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11200746)

  • 41. Neurotrophin system expression in human pulmonary carcinoid tumors.
    Ricci A; Graziano P; Mariotta S; Cardillo G; Sposato B; Terzano C; Bronzetti E
    Growth Factors; 2005 Dec; 23(4):303-12. PubMed ID: 16338793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids.
    Saqi A; Alexis D; Remotti F; Bhagat G
    Am J Clin Pathol; 2005 Mar; 123(3):394-404. PubMed ID: 15716236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids.
    Krishnamurthy S; Dayal Y
    Am J Surg Pathol; 1997 Mar; 21(3):327-33. PubMed ID: 9060603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased immunoreactivity of CD99 is an independent predictor of regional lymph node metastases in pulmonary carcinoid tumors.
    Pelosi G; Leon ME; Veronesi G; Spaggiari L; Pasini F; Viale G
    J Thorac Oncol; 2006 Jun; 1(5):468-77. PubMed ID: 17409901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DNA topoisomerase II-alpha in pulmonary carcinoid tumors.
    Resl M; Simek J; Bukac J; Rothröckel P; Siller J
    Pathol Res Pract; 2001; 197(3):169-73. PubMed ID: 11314780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Proliferative activity in pulmonary carcinoids].
    Resl M; Bukac J; Simek J; Siller J; Rothröckel P
    Cesk Patol; 2000 Jan; 36(1):32-4. PubMed ID: 10838756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship of transforming growth factor beta 1 to angiogenesis in gastric carcinoma.
    Choi YH; Choi KC; Park YE
    J Korean Med Sci; 1997 Oct; 12(5):427-32. PubMed ID: 9364301
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LYVE-1 immunocytochemical staining for gastrointestinal carcinoids.
    Tomita T
    Pathology; 2009; 41(3):248-53. PubMed ID: 19291537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic Significance of CD44 and Orthopedia Homeobox Protein (OTP) Expression in Pulmonary Carcinoid Tumours.
    Papaxoinis G; Nonaka D; O'Brien C; Sanderson B; Krysiak P; Mansoor W
    Endocr Pathol; 2017 Mar; 28(1):60-70. PubMed ID: 27873160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression.
    Rapa I; Votta A; Felice B; Righi L; Giorcelli J; Scarpa A; Speel EJ; Scagliotti GV; Papotti M; Volante M
    Neuroendocrinology; 2015; 101(3):246-55. PubMed ID: 25791280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA cytophotometry and prognosis in typical and atypical bronchopulmonary carcinoids. A clinicomorphologic study of 100 neuroendocrine lung tumors.
    Padberg BC; Woenckhaus J; Hilger G; Beccu L; Jochum W; Range U; Kastendieck H; Schröder S
    Am J Surg Pathol; 1996 Jul; 20(7):815-22. PubMed ID: 8669529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of beta-catenin, TGF beta 3, NGF2, FGF2, IGFR2, and BMP4 in the pathogenesis of mesenteric sclerosis and angiopathy in midgut carcinoids.
    Zhang PJ; Furth EE; Cai X; Goldblum JR; Pasha TL; Min KW
    Hum Pathol; 2004 Jun; 35(6):670-4. PubMed ID: 15188132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modeling Lung Carcinoids with Zebrafish Tumor Xenograft.
    Carra S; Gaudenzi G; Dicitore A; Cantone MC; Plebani A; Saronni D; Zappavigna S; Caraglia M; Candeo A; Bassi A; Persani L; Vitale G
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bone marrow angiogenesis in systemic mast cell disease.
    Baek JY; Li CY; Pardanani A; Butterfield JH; Tefferi A
    J Hematother Stem Cell Res; 2002 Feb; 11(1):139-46. PubMed ID: 11847010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of tyrosine kinase receptors in lung carcinoids.
    Granberg D; Wilander E; Oberg K
    Tumour Biol; 2006; 27(3):153-7. PubMed ID: 16612146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Typical and atypical bronchopulmonary carcinoid tumors: a clinicopathologic and KI-67-labeling study.
    Costes V; Marty-Ané C; Picot MC; Serre I; Pujol JL; Mary H; Baldet P
    Hum Pathol; 1995 Jul; 26(7):740-5. PubMed ID: 7628845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(4A):2701-10. PubMed ID: 9703932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chromosomal instability is more frequent in metastasized than in non-metastasized pulmonary carcinoids but is not a reliable predictor of metastatic potential.
    Warth A; Herpel E; Krysa S; Hoffmann H; Schnabel PA; Schirmacher P; Mechtersheimer G; Bläker H
    Exp Mol Med; 2009 May; 41(5):349-53. PubMed ID: 19307755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictive Indicators of Survival in Patients With Surgically Resected Lung Carcinoid Tumors at a Greek Medical Center.
    Georgakopoulou VE; Zygouris E; Nikokiris C; Damaskos C; Pierrakou A; Garmpis N; Garmpi A; Sklapani P; Aravantinou A; Trakas N; Janinis J; Dahabreh J
    Cureus; 2020 Sep; 12(9):e10300. PubMed ID: 32923302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor.
    Vesterinen T; Mononen S; Salmenkivi K; Mustonen H; Räsänen J; Salo JA; Ilonen I; Knuuttila A; Haglund C; Arola J
    Acta Oncol; 2018 Aug; 57(8):1109-1116. PubMed ID: 29463166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.